tiprankstipranks
Ultragenyx Pharmaceutical (DE:UP0)
FRANKFURT:UP0

Ultragenyx Pharmaceutical (UP0) Stock Investors

0 Followers
Based on 728,053 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DE:UP0
On average, investors allocate 4.06% of their portfolios to DE:UP0
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding UP0

1.4%
Last 7
Days
6.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:UP0, out of 728,053 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

UP0 Investor Activity

No data currently available
Based on the activity of 13,678 investors who made their portfolios public
The table shows changes in UP0 in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

UP0 Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.78%
-0.51%
-2.18%
39.60B
Technology
ServiceNow
4.03%
+0.12%
+0.15%
150.84B
Technology
DraftKings
7.11%
-1.06%
-3.36%
37.89B
Consumer Cyclical
Marvell
4.86%
+1.47%
+7.83%
58.78B
Technology
Block
4.53%
-1.25%
-6.79%
45.25B
Technology
Merck & Company
4.11%
-0.37%
-0.37%
319.59B
Healthcare
Mercadolibre
5.30%
-0.47%
-2.35%
71.78B
Consumer Cyclical
Micron
5.82%
+0.42%
+26.38%
134.40B
Technology
Salesforce
4.97%
+1.29%
-0.87%
264.71B
Technology
Mastercard
4.76%
-0.18%
-1.76%
428.93B
Financial
Based on the activity of 728,053 active portfolios
Open your Smart Portfolio

UP0 Investor Analysis

DE:UP0 investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.6%
of DE:UP0 holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
DE:UP0 investors between 35–55

Between 35–55

5.9%
Last 30 days
Holdings Change
52.7%
of DE:UP0 holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
DE:UP0 investors over 55

Over 55

5.4%
Last 30 days
Holdings Change
38.7%
of DE:UP0 holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of DE:UP0 stock investors
See who invests in UP0 according to age group and performance.

FAQ

How many retail Investors hold DE:UP0?
<0.1% of TipRanks' retail investors hold DE:UP0 in their portfolios.
    What is DE:UP0 Investor Sentiment?
    DE:UP0’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DE:UP0 in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of DE:UP0 in the last 7 days.
        What percentage of retail investors changed their holding of DE:UP0 in the last 30 days?
        ▼ 6.2% of TipRanks' retail investors changed their holding of DE:UP0 in the last 30 days.
          What is the average age of retail investors who hold DE:UP0?
          The average age of DE:UP0 Holders is between 35–55.
            What other stocks have DE:UP0 investors also bought?
            DE:UP0 Investors also bought TTD, NOW, DKNG, MRVL, SQ, MRK, MELI, MU, CRM, MA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis